Across TCGA pan-cancer cohorts, MTND1P17 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MTND1P17 data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MTND1P17 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P17 expression acts as an unfavorable survival marker, although some lineages such as KIRC and ESCA show a favorable association.
SKCM, KIRC, and MESO are the cancer types where MTND1P17 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.